Feng Chi Biotech Corp.

TWO:6744 Taiwan Biotechnology
Market Cap
$7.45 Million
NT$246.40 Million TWD
Market Cap Rank
#33621 Global
#1892 in Taiwan
Share Price
NT$16.00
Change (1 day)
+0.00%
52-Week Range
NT$16.00 - NT$18.20
All Time High
NT$18.20
About

Feng Chi Biotech Corp. engages in the wholesale and retail of medical equipment and precision instruments and biotechnology services in Taiwan and internationally. The company provides preimplantation genetic testing, prenatal testing, precision medicine, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services. It also distributes various geneti… Read more

Feng Chi Biotech Corp. - Asset Resilience Ratio

Latest as of June 2025: 58.42%

Feng Chi Biotech Corp. (6744) has an Asset Resilience Ratio of 58.42% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$178.35 Million
Cash + Short-term Investments
Total Assets
NT$305.31 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Feng Chi Biotech Corp.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Feng Chi Biotech Corp.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$178.35 Million 58.42%
Total Liquid Assets NT$178.35 Million 58.42%

Asset Resilience Insights

  • Very High Liquidity: Feng Chi Biotech Corp. maintains exceptional liquid asset reserves at 58.42% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Feng Chi Biotech Corp. Industry Peers by Asset Resilience Ratio

Compare Feng Chi Biotech Corp.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Feng Chi Biotech Corp. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Feng Chi Biotech Corp..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 60.67% NT$181.43 Million NT$299.07 Million -1.07pp
2023-12-31 61.73% NT$185.83 Million NT$301.03 Million +6.76pp
2022-12-31 54.97% NT$169.50 Million NT$308.36 Million -8.50pp
2021-12-31 63.47% NT$181.97 Million NT$286.69 Million +2.74pp
2020-12-31 60.74% NT$172.48 Million NT$283.99 Million +0.97pp
2019-12-31 59.77% NT$159.77 Million NT$267.32 Million --
pp = percentage points